International Clinical Trial: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987513) titled 'A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight' on May 16.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Altimmune, Inc.

Condition: Alcohol Use Disorder (AUD)

Intervention: Drug: Pemvidutide

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: ...